276 related articles for article (PubMed ID: 15784577)
1. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.
Levels JH; Marquart JA; Abraham PR; van den Ende AE; Molhuizen HO; van Deventer SJ; Meijers JC
Infect Immun; 2005 Apr; 73(4):2321-6. PubMed ID: 15784577
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins.
Wurfel MM; Wright SD
Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933
[TBL] [Abstract][Full Text] [Related]
3. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.
Vreugdenhil AC; Snoek AM; van 't Veer C; Greve JW; Buurman WA
J Clin Invest; 2001 Jan; 107(2):225-34. PubMed ID: 11160139
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes.
Vesy CJ; Kitchens RL; Wolfbauer G; Albers JJ; Munford RS
Infect Immun; 2000 May; 68(5):2410-7. PubMed ID: 10768924
[TBL] [Abstract][Full Text] [Related]
5. Distribution and kinetics of lipoprotein-bound endotoxin.
Levels JH; Abraham PR; van den Ende A; van Deventer SJ
Infect Immun; 2001 May; 69(5):2821-8. PubMed ID: 11292694
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid.
Wurfel MM; Wright SD
J Immunol; 1997 Apr; 158(8):3925-34. PubMed ID: 9103463
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
Wurfel MM; Hailman E; Wright SD
J Exp Med; 1995 May; 181(5):1743-54. PubMed ID: 7536794
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.
Wurfel MM; Kunitake ST; Lichenstein H; Kane JP; Wright SD
J Exp Med; 1994 Sep; 180(3):1025-35. PubMed ID: 8064223
[TBL] [Abstract][Full Text] [Related]
9. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein.
Vosbeck K; Tobias P; Mueller H; Allen RA; Arfors KE; Ulevitch RJ; Sklar LA
J Leukoc Biol; 1990 Feb; 47(2):97-104. PubMed ID: 2154525
[TBL] [Abstract][Full Text] [Related]
10. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins.
Kitchens RL; Thompson PA
J Endotoxin Res; 2003; 9(2):113-8. PubMed ID: 12803885
[TBL] [Abstract][Full Text] [Related]
11. Molecular and macromolecular specificity of human plasma phospholipid transfer protein.
Rao R; Albers JJ; Wolfbauer G; Pownall HJ
Biochemistry; 1997 Mar; 36(12):3645-53. PubMed ID: 9132017
[TBL] [Abstract][Full Text] [Related]
12. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein.
Thompson PA; Kitchens RL
J Immunol; 2006 Oct; 177(7):4880-7. PubMed ID: 16982930
[TBL] [Abstract][Full Text] [Related]
13. LPS binding protein does not participate in the pharmacokinetics of E5564.
Kaneko K; Ueda R; Kawata T; Ishizaka S; Yoshimura T
J Endotoxin Res; 2004; 10(3):185-94. PubMed ID: 15198853
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons.
Vreugdenhil AC; Rousseau CH; Hartung T; Greve JW; van 't Veer C; Buurman WA
J Immunol; 2003 Feb; 170(3):1399-405. PubMed ID: 12538700
[TBL] [Abstract][Full Text] [Related]
15. Plasma PLTP (phospholipid-transfer protein): an emerging role in 'reverse lipopolysaccharide transport' and innate immunity.
Gautier T; Lagrost L
Biochem Soc Trans; 2011 Aug; 39(4):984-8. PubMed ID: 21787334
[TBL] [Abstract][Full Text] [Related]
16. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein.
Hailman E; Albers JJ; Wolfbauer G; Tu AY; Wright SD
J Biol Chem; 1996 May; 271(21):12172-8. PubMed ID: 8647810
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoproteins (HDL) inhibit endotoxin-induced leukocyte adhesion on endothelial cells in rats: effect of the acute-phase HDL.
Thaveeratitham P; Khovidhunkit W; Patumraj S
Clin Hemorheol Microcirc; 2007; 36(1):1-12. PubMed ID: 17211057
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast.
Ren L; Leung WK; Loo TW; Jin L
J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094
[TBL] [Abstract][Full Text] [Related]
19. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure.
Levels JH; Lemaire LC; van den Ende AE; van Deventer SJ; van Lanschot JJ
Crit Care Med; 2003 Jun; 31(6):1647-53. PubMed ID: 12794399
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.
Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C
Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
